When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. What does Vacepsa cost on Medicare? - AOL

   www.aol.com/lifestyle/does-vacepsa-cost-medicare...

   Vascepa (icosapent ethyl) is a brand-name prescription medication. Doctors may prescribe it alongside dietary changes to reduce levels of triglyceride (a type of fat) in adults with severe ...

3. Ethyl eicosapentaenoic acid - Wikipedia

   en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

   Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL.

4. How Much Does Vascepa Cost on Medicare? - AOL

   www.aol.com/much-does-vascepa-cost-medicare...

   That said, according to Vascepa’s manufacturer’s data, the drug is covered without restrictions for more than 90% of people enrolled in Medicare Part D. If your plan covers this drug, your ...

5. Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA ...

   lite.aol.com/tech/story/0022/20240909/9227242.htm

   VASCEPA was initially launched in the United States in 2013 based on the drug’s initial FDA approved indication for use as an adjunct therapy to diet to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. Since launch, VASCEPA has been prescribed more than ten million times.

6. The Most Common Antidepressants (& How to Get Them) - AOL

   www.aol.com/most-common-antidepressants-them...

   These are the most common antidepressants prescribed to patients: Selective serotonin reuptake inhibitors (SSRIs) ... 6 Types of Depression Medications: A Complete Guide. Show comments ...

7. Amarin Corporation - Wikipedia

   en.wikipedia.org/wiki/Amarin_Corporation

   Amarin´s sole product VASCEPA® came on the market in 2013 for triglyceride levels >=500 milligrams per deciliter. In December 2019, the FDA approved "...the use of Vascepa (icosapent ethyl) as an adjunctive (secondary) therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels (a type of fat in the blood) of 150 milligrams per deciliter or higher.